These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30282055)

  • 1. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
    de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
    Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
    JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
    Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
    Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial.
    Limonte CP; Zelnick LR; Ruzinski J; Hoofnagle AN; Thadhani R; Melamed ML; Lee IM; Buring JE; Sesso HD; Manson JE; de Boer IH
    Diabetologia; 2021 Feb; 64(2):437-447. PubMed ID: 33098434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
    Bassuk SS; Manson JE; Lee IM; Cook NR; Christen WG; Bubes VY; Gordon DS; Copeland T; Friedenberg G; D'Agostino DM; Ridge CY; MacFadyen JG; Kalan K; Buring JE
    Contemp Clin Trials; 2016 Mar; 47():235-43. PubMed ID: 26767629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
    Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
    JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
    JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial.
    Taheri S; Asim M; Al Malki H; Fituri O; Suthanthiran M; August P;
    Trials; 2018 Apr; 19(1):230. PubMed ID: 29665833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.
    Okereke OI; Reynolds CF; Mischoulon D; Chang G; Cook NR; Copeland T; Friedenberg G; Buring JE; Manson JE
    Contemp Clin Trials; 2018 May; 68():133-145. PubMed ID: 29526608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
    Elajami TK; Alfaddagh A; Lakshminarayan D; Soliman M; Chandnani M; Welty FK
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
    Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
    Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).
    LeBoff MS; Yue AY; Copeland T; Cook NR; Buring JE; Manson JE
    Contemp Clin Trials; 2015 Mar; 41():259-68. PubMed ID: 25623291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITamin D and OmegA-3 triaL (VITAL).
    Soens MA; Sesso HD; Manson JE; Fields KG; Buring JE; Lee IM; Cook NR; Kim E; Bubes V; Dushkes R; Serhan CN; Rathmell JP
    Pain; 2024 Mar; 165(3):635-643. PubMed ID: 37878483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.
    Orkaby AR; Dushkes R; Ward R; Djousse L; Buring JE; Lee IM; Cook NR; LeBoff MS; Okereke OI; Copeland T; Manson JE
    JAMA Netw Open; 2022 Sep; 5(9):e2231206. PubMed ID: 36098968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
    JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial.
    Chandler PD; Chen WY; Ajala ON; Hazra A; Cook N; Bubes V; Lee IM; Giovannucci EL; Willett W; Buring JE; Manson JE;
    JAMA Netw Open; 2020 Nov; 3(11):e2025850. PubMed ID: 33206192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Stijnen T; Gemen EF; Kusters R; Giltay EJ
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1676-83. PubMed ID: 25104273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.
    Bischoff-Ferrari HA; Vellas B; Rizzoli R; Kressig RW; da Silva JAP; Blauth M; Felson DT; McCloskey EV; Watzl B; Hofbauer LC; Felsenberg D; Willett WC; Dawson-Hughes B; Manson JE; Siebert U; Theiler R; Staehelin HB; de Godoi Rezende Costa Molino C; Chocano-Bedoya PO; Abderhalden LA; Egli A; Kanis JA; Orav EJ;
    JAMA; 2020 Nov; 324(18):1855-1868. PubMed ID: 33170239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Vitamin D3 in combination with Omega-3 Polyunsaturated Fatty Acids on NETosis in Type 2 Diabetes Mellitus Patients.
    Basyreva LY; Vakhrusheva TV; Letkeman ZV; Maximov DI; Fedorova EA; Panasenko ОM; Ostrovsky EM; Gusev SA
    Oxid Med Cell Longev; 2021; 2021():8089696. PubMed ID: 34721760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
    Hahn J; Cook NR; Alexander EK; Friedman S; Walter J; Bubes V; Kotler G; Lee IM; Manson JE; Costenbader KH
    BMJ; 2022 Jan; 376():e066452. PubMed ID: 35082139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.